MARKET

ABBV

ABBV

Abbvie Inc
NYSE
220.89
-1.55
-0.70%
After Hours: 220.32 -0.57 -0.26% 19:23 02/11 EST
OPEN
222.27
PREV CLOSE
222.44
HIGH
224.15
LOW
218.05
VOLUME
8.07M
TURNOVER
--
52 WEEK HIGH
241.12
52 WEEK LOW
159.05
MARKET CAP
390.40B
P/E (TTM)
166.67
1D
5D
1M
3M
1Y
5Y
1D
AbbVie Updates Phase 2 Elezanumab Study in Acute Cervical Spinal Cord Injury: What Investors Should Watch
TipRanks · 7h ago
P/E Ratio Insights for AbbVie
Benzinga · 10h ago
Assessing AbbVie (ABBV) Valuation After Strong Q4 Results And New Rinvoq Filings
Simply Wall St · 13h ago
AbbVie’s Real-World Migraine Study Could Quietly Boost Ubrogepant’s Market Potential
TipRanks · 1d ago
Dividend Kings: No Ideal Buys In February's 57
Seeking Alpha · 1d ago
Gilead Sciences: Buy This Stock For Both Dividend And Growth
Seeking Alpha · 1d ago
Did AbbVie’s (ABBV) Q4 Beat and RINVOQ Vitiligo Filings Just Reframe Its Immunology Story?
Simply Wall St · 1d ago
Weekly Report: what happened at ABBV last week (0202-0206)?
Weekly Report · 2d ago
More
About ABBV
AbbVie Inc. is a global, diversified research-based biopharmaceutical company. It is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Immunology products include rheumatology, dermatology and gastroenterology. Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere and Epkinly. Aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Eye Care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, and other eye care. Other key products include Mavyret/Maviret, Creon, and Linzess/Constella. Its investigational candidate, bretisilocin, is for the treatment of patients with moderate-to-severe major depressive disorder (MDD).

Webull offers AbbVie Inc stock information, including NYSE: ABBV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABBV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABBV stock methods without spending real money on the virtual paper trading platform.